Active, Not Recruiting
A Study of NTX-1088, a Monoclonal Antibody Targeting the Poliovirus Receptor (PVR, CD155), as Monotherapy and Combined With Pembrolizumab
NCT05378425
- Conditions
- Advanced Solid Tumor, Cancer, Locally Advanced Solid Tumor, +7 more
- Locations
-
- City of Hope Duarte, California, United States
- Ochsner Clinic Foundation New Orleans, Louisiana, United States
- The University of Texas MD Anderson Cancer Center Houston, Texas, United States
- Hadassah Medical Center Jerusalem, Israel